Stephen J. Tulipano

Chief Financial Officer, JAVELIN PHARMACEUTICALS, INC.

Companies

Stoke Therapeutics, Inc.Chief financial officer Jun 18, 2019 to Jun 7, 2024¹
Aldeyra Therapeutics, Inc.Chief financial officer Jun 26, 2014 to Mar 8, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Stoke Therapeutics, Inc. STOK20,746 shares³$517.8K at $24.96Mar 19, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 19, 2024Sold 4,116 shares at $6.10 of Stoke Therapeutics, Inc.³
Mar 15, 2024Exercised options 13,100 shares of Stoke Therapeutics, Inc.³
Jun 2, 2022Exercised options 11,160 shares at $4.48 of Stoke Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARStoke Therapeutics, Inc., Chief financial officer
2
SEC EDGARAldeyra Therapeutics, Inc., Chief financial officer
3
SEC EDGARStoke Therapeutics, Inc. shares after the filing of Mar 19, 2024
4
SEC EDGARForm 4 filed Jun 3, 2022